Related Articles
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer
The use of treosulfan and gemcitabine in the treatment of platinum-resistant ovarian cancer
Expression of UCP2 is associated with sensitivity to platinum‑based chemotherapy for ovarian serous carcinoma
TBX2 expression is associated with platinum‑sensitivity of ovarian serous carcinoma
Long‑term survival of a <em>BRCA2</em> mutation carrier following second ovarian cancer relapse using PARPi therapy: A case report